Thousands of people in Britain are experiencing a enigmatic and incapacitating skin condition that has confounded medical professionals. Sufferers describe their skin as becoming severely inflamed, cracked and peeling, frequently across their whole body, yet many doctors have trouble diagnosing or treating the condition. The condition, called topical steroid withdrawal (TSW) or red skin syndrome, has created considerable interest on social media, with clips featuring patients’ experiences accumulating over one billion views on TikTok alone. Even though it impacts a growing number of people, TSW remains so poorly understood that some general practitioners and dermatologists query whether it actually exists at all. Now, in a first-of-its-kind move, researchers in the UK are undertaking a large-scale study to investigate what is behind these mysterious symptoms and reasons why some people develop the condition whilst others do not.
The Puzzling Illness Sweeping Across the UK
Bethany Gamble’s case exemplifies the profound effects of topical steroid withdrawal on sufferers’ lives. The 21-year-old from Birmingham had handled her eczema effectively with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became intensely inflamed and red, cracking and oozing whilst the itching became what she describes as “bone deep”. Within two years, the pain had become so intense that she was confined to her bed, needing constant care from her mother. Most troubling, Bethany found herself repeatedly dismissed by healthcare providers who ascribed her symptoms to standard eczema and kept prescribing the very treatments she believed were causing her suffering.
The medical establishment remains divided on how to approach TSW, with deep divisions about its core nature. Some experts view it as a severe allergic response to the topical steroids that serve as the primary treatment for eczema across the NHS. Others contend it amounts to a serious exacerbation of existing skin conditions rather than a unique syndrome, whilst a minority are sceptical of its existence. This professional uncertainty has placed patients like Bethany stuck in a diagnostic uncertainty, finding it hard to obtain suitable treatment. The absence of agreement has led Professor Sara Brown at the University of Edinburgh to establish the inaugural major UK research project studying TSW, supported by the National Eczema Society.
- Symptoms comprise significant swelling, skin fissuring and intense itching across the body
- Patients document “elephant skin” thickening and extreme shedding of dead skin cells
- Medical professionals commonly disregard TSW as typical dermatitis or refuse to acknowledge it
- The condition may prove so debilitating that sufferers become unable to carry out everyday tasks
Living with Topical Steroid Withdrawal
From Manageable Eczema to Debilitating Symptoms
For numerous patients, withdrawal from topical steroids constitutes a catastrophic deterioration from a previously stable dermatological condition. What starts with occasional itching in areas of skin fold can rapidly escalate into a full-body inflammatory response that renders patients incapable of functioning. The transition often occurs abruptly, unexpectedly, transforming a manageable chronic condition into an severe medical emergency. People describe their skin turning impossibly hot, inflamed and red, with significant cracking and weeping that requires ongoing care. The bodily burden is worsened by fatigue, as the relentless itching prevents sleep and healing, establishing a destructive cycle of deterioration.
The rate at which TSW progresses takes many sufferers by surprise. Those who have dealt with eczema for years, sometimes decades, are unprepared for the magnitude of symptoms that appear when their condition suddenly worsens. Simple daily activities become formidable obstacles: showering becomes unbearable, dressing demands help, and preserving hygiene demands enormous effort. Some patients report feeling as though their skin is being ravaged from within, with inflammation moving through their body in patterns that differ markedly to their past episodes. This dramatic transformation often drives sufferers to pursue immediate medical attention, only to face disbelief from healthcare professionals.
The Quest for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the medical gaslighting that frequently accompanies it. Patients presenting with severe, unexplained symptoms are routinely told they merely suffer from eczema flaring up, despite their assertion that this is essentially distinct from anything they’ve experienced before. Doctors frequently react by recommending higher-strength steroids or higher dosages, potentially worsening the very condition patients believe the creams caused. This pattern of rejection leaves sufferers feeling abandoned by the medical establishment, forced to navigate their illness alone whilst being informed that their personal experience lacks validity. Many patients report experiencing repeated invalidation, their worries disregarded as anxiety or psychological rather than actual physical health issues.
The lack of professional agreement has established a dangerous gap between what patients report and professional recognition. Without clear diagnostic criteria or established treatment protocols, general practitioners and skin specialists find it difficult to diagnose TSW or provide suitable care. Some practitioners remain completely sceptical the condition exists, viewing all severe presentations as standard eczema or other known dermatological conditions. This professional uncertainty translates into diagnostic delays, unsuitable therapies and significant emotional suffering for patients already suffering physically. The increased prominence of TSW on social media has drawn attention to this diagnostic gap, prompting researchers to investigate what thousands of people claim to be experiencing, even as the medical establishment remains divided on how to respond.
- Symptoms can emerge suddenly in people with formerly controlled eczema managed by topical steroids
- Patients frequently encounter scepticism from medical practitioners who attribute deterioration to typical eczema exacerbations
- Healthcare providers remain divided on whether TSW is a genuine condition or severe eczema exacerbation
- Absence of established diagnostic standards means many sufferers find it difficult to obtain appropriate treatment and assistance
- Social media has magnified patient voices, with TSW hashtags accumulating more than one billion views worldwide
Ethnic Inequalities in Assessment and Clinical Management
The diagnostic complexities surrounding TSW become more acute amongst those with darker complexions, where symptoms can be considerably more difficult to recognise visually. Erythema and inflammatory responses, the characteristic indicators of TSW in those with lighter complexions, present distinctly across different ethnic groups, yet many assessment protocols remain centred on how the condition appears in white patients. This disparity means that Black, Asian and other people of colour experiencing TSW frequently encounter substantially longer periods in acknowledgement and confirmation. Clinical practitioners trained primarily on appearances in lighter skin types may miss or misread the characteristic signs, causing continued misidentification and inappropriate treatment recommendations that can worsen symptoms.
Research into TSW has traditionally overlooked the experiences of people with deeper skin tones, sustaining a pattern where their condition goes insufficiently documented and inadequately researched. The social media conversations shaping TSW discourse have been largely shaped by individuals with lighter complexions, risking distortion of medical understanding and community understanding. As Professor Sara Brown’s pioneering British research advances, guaranteeing inclusive participation amongst research participants will be crucial to developing truly inclusive diagnostic criteria and treatment approaches. Without deliberate efforts to centre the experiences of all ethnic groups, treatment inequalities in TSW recognition and management risk widening further, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Research and Treatment Solutions Developing
First Major UK Study Underway
Professor Sara Brown’s pioneering research at the University of Edinburgh constitutes a watershed moment for TSW sufferers pursuing validation and understanding. Funded by the National Eczema Society, the study has recruited hundreds of participants in the UK to explore the physiological processes driving topical steroid withdrawal. By assessing symptoms, saliva samples and skin biopsies, researchers aim to identify why particular individuals experience TSW whilst others using identical steroid regimens do not. This scientific scrutiny marks a significant shift from dismissal to rigorous examination.
The research team working alongside Dr Alice Burleigh from advocacy group for patients Scratch That, brings both medical knowledge and personal experience to the research. Their partnership approach accepts that patients themselves hold essential understanding into their health situations. Professor Brown has noted patterns in TSW that cannot be accounted for by traditional understanding of eczema, including characteristic “elephant skin” thickening, extreme shedding and distinctly marked inflammatory patches. The research findings could fundamentally reshape how healthcare practitioners approach diagnosis and management of this disabling illness.
Treatment Options and Associated Limitations
Currently, treatment options for TSW are quite limited and often unsatisfactory. Many clinicians keep prescribing topical steroids notwithstanding evidence implying they might intensify symptoms in vulnerable patients. Some patients describe short-term improvement from emollients, antihistamines and systemic medications, though responses vary considerably. Dermatologists remain divided on best treatment approaches, with some recommending full steroid withdrawal whilst others advocate phased withdrawal. This lack of consensus leaves patients navigating their care journeys predominantly by themselves, relying heavily on peer support networks and online communities for guidance.
Psychological support and specialist dermatological care may provide advantages, yet access is inconsistent across the NHS. Some patients have investigated complementary methods including dietary modifications, environmental controls and whole-person treatment approaches, though scientific evidence validating such approaches remains sparse. The absence of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollients and moisturisers to support skin barrier function and decrease water loss
- Antihistamine medications to alleviate itching and associated sleep disruption in flare episodes
- Systemic corticosteroids or immune-suppressing agents for severe cases under specialist supervision
- Therapeutic counselling to address emotional distress and worry stemming from prolonged skin suffering
Voices of Hope and Determination
Despite the lack of clarity surrounding TSW and the frequently dismissive perspectives from medical practitioners, patients are gaining resilience in shared community and collective experience. Digital support communities have proven vital for those struggling with the condition, offering validation and practical advice when traditional medicine has let them down. Many sufferers describe the moment they discovered the TSW hashtag as transformative—finally finding others with the same symptoms and recognising they were not alone in their experience. This unified voice has proven powerful enough to trigger the first serious research efforts, demonstrating that patient-led campaigns can drive medical progress even when established institutions remain sceptical.
Bethany Gamble and others like her are committed to raise awareness and campaign for appropriate acknowledgement of TSW within the healthcare sector. Their readiness to discuss intimate experiences of their difficulties on online platforms has made discussions more commonplace around a illness that numerous physicians still decline to recognise. These individuals are not remaining passive for responses; they are actively participating in research studies, documenting their symptoms carefully, and requiring that their accounts be given proper consideration. Their resilience in the midst of persistent distress and dismissive healthcare practices offers hope that responses might prove to be within attainment, and that upcoming sufferers will obtain the recognition and support they so desperately need.
- Community-driven research projects are filling gaps overlooked by traditional medical institutions and accelerating understanding of TSW
- Online communities offer psychological assistance, practical coping strategies, and peer validation for isolated sufferers worldwide
- Advocacy efforts are incrementally changing clinical attitudes, prompting dermatologists to examine rather than overlook individual accounts
